Azmi Nabulsi, Chief Operating Officer at Phathom Pharmaceuticals, Inc. (PHAT), sold 26,776 shares at $46.16 ($1.2M) on 2021-03-02, disclosed to the SEC on 2021-03-03.
Open-market sale of $1.2M PHAT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.77 | 3,825 | $175K | 14.2% |
| 2 | $45.77 | 3,825 | $175K | 14.2% |
| 3 | $46.05 | 1,548 | $71K | 5.8% |
| 4 | $46.05 | 1,548 | $71K | 5.8% |
| 5 | $44.60 | 600 | $27K | 2.2% |
| 6 | $45.17 | 1,600 |
| $72K |
| 5.9% |
| 7 | $46.16 | 4,833 | $223K | 18.1% |
| 8 | $46.16 | 4,833 | $223K | 18.1% |
| 9 | $46.23 | 2,070 | $96K | 7.8% |
| 10 | $46.23 | 2,070 | $96K | 7.8% |
| 11 | $46.73 | 24 | $1K | 0.1% |
| Total | $45.95 avg | 26,776 | $1.2M | 100% |
| Filing → |
| PHAT | SELL | 2024-07-17 | $256K | — | Filing → |
| PHAT | BUY | 2023-04-11 | $83K | — | Filing → |
| PHAT | BUY | 2022-05-16 | $163K | — | Filing → |